𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular basis for improved anthrax vaccines

✍ Scribed by Robert N. Brey

Book ID
113417930
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
382 KB
Volume
57
Category
Article
ISSN
0169-409X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recent advances in the development of an
Recent advances in the development of an improved, human anthrax vaccine
✍ Bruce E. Ivins; Susan L. Welkos πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 896 KB

Human anthrax vaccines currently licensed in the United States and Western Europe consist of alum-precipitated or aluminum hydroxide-adsorbed supernatant material from fermentor cultures of toxigenic, nonencapsulated strains of Bacillus anthracis. These vaccines have several drawbacks, including the

Prospects for improved bluetongue vaccin
Prospects for improved bluetongue vaccines
✍ Roy, Polly; Boyce, Mark; Noad, Robert πŸ“‚ Article πŸ“… 2009 πŸ› Nature Publishing Group 🌐 English βš– 935 KB
Anthrax vaccine powder formulations for
Anthrax vaccine powder formulations for nasal mucosal delivery
✍ Ge Jiang; Sangeeta B. Joshi; Laura J. Peek; Duane T. Brandau; Juan Huang; Matthe πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 490 KB

Anthrax remains a serious threat worldwide as a bioterror agent. A second-generation anthrax vaccine currently under clinical evaluation consists of a recombinant Protective Antigen (rPA) of Bacillus anthracis. We have previously demonstrated that complete protection against inhalational anthrax can